Oral cavity and oropharyngeal cancers are typically grouped under the general term, "oral cancer." Yet, the incidence of oropharyngeal cancers is increasing in the United States, while the incidence of oral cavity cancers has declined. These 2 distinct but conflated groups of oral cancers are attributed to different risk factors. Incidence and survival trends were examined across US population groups and by anatomical subsite. Disparities in incidence and survival by sex, race/ethnicity, and subsite were identified. Risk factors are complex, interactive, and not fully identified. Cancer control research illustrates health disparities in access to care and patient outcomes. Database and supplemental searches yielded 433 articles published between 1995 and 2016 characterizing aspects of oral cancer epidemiology relating to incidence, survival, risk, disparities, and cancer control. Oral cavity cancer survival in black men remains the most intractable burden. Although understanding of oral cancer etiology is improving, application to policy is limited. Cancer control efforts are diverse, sporadic, limited in scope, and generally lacking in success, and they need stratification by oral cavity cancers/oropharyngeal cancers. Further intervention and epidemiologic research, improved workforce capacity, and integrated care delivery are identified as important directions for public health policy. Sustained, multilevel campaigns modeled on tobacco control success are suggested.
INTRODUCTION
Oral cavity and oropharyngeal cancers are typically grouped together under the general term, "oral cancer." In this review the term, "oral cavity cancers," includes these subsites: anterior two-thirds of the tongue (oral tongue), gums, floor of mouth, hard palate, and buccal mucosa. Oropharyngeal cancers include the posterior one-third of the tongue (base of tongue), soft palate, tonsils, and "other" oropharynx (1, 2) . Despite the usual conflation of these cancers as a single group, as demonstrated in this review, it is well established that the incidence of oropharyngeal cancers is on the increase in the United States, while the incidence of oral cavity cancers has declined. Moreover, these 2 distinct groups of oral cancers are generally attributed to different risk factors. While oropharyngeal cancers tend to be associated with human papillomavirus (HPV), oral cavity cancers are more likely to be associated with tobacco and heavy alcohol use (3). These 2 groups of oral cancers are also associated with different population groups. In the United States, oral cavity cancers are more common in older, male populations and particularly in black men. Oropharyngeal cancers are more common in younger, white, and male populations (1, 2, 4) .
This review examines the epidemiologic literature on oral cavity cancers and oropharyngeal cancers to assess US trends in disease incidence and survival by oral subsite and to highlight disparities in disease burden. We describe both established and emerging risk factors for oral cancers. The literature on incidence, survival, and risk is then considered in light of prevention and early detection strategies and sources of disparities to identify environmental, policy, and healthcare system factors that can influence outcomes and may offer opportunities for more effective interventions. Strategies for improvement in oral cancer control are proposed.
METHODS
A targeted literature review was undertaken through March 2016 to identify relevant epidemiologic articles on oral cancers. Searches were conducted in PubMed, MED-LINE, and the Cochrane Library. Search terms for the database searches, including Medical Subject Headings (MeSH) and other relevant keywords, included "mouth neoplasms," "oropharyngeal neoplasms," "incidence," "survival," "costs and cost analysis," "health care costs," "health services accessibility," "health status disparities," "healthcare disparities," "minority health," "alphapapillomavirus," "behavior, risk," "risk reduction behavior," "risk factors," "risk assessment," "preventive health services," and "early detection of cancer."
In addition to the literature searches, reference lists in identified articles were reviewed for additional articles. Finally, subject-expert consultations were sought to ensure a comprehensive collection of articles.
Articles were included in the search if the publication date was between 1995 and 2016; if they were published in English; and, for clinical trials, if at least 1 trial location was in the United States. The start date of 1995 was chosen to provide 2 decades of review and to work in conjunction with the emerging scholarly focus on HPV in head and neck cancer (5) and with the onset of the diverging trends of oral cavity and oropharyngeal cancers (6) . Articles were excluded if they focused on the nasopharynx, hypopharynx, lip, or salivary gland cancers that are etiologically distinct from most other oral cancers. Editorials and nonsystematic literature reviews were also excluded. A final list of 433 articles was selected for consideration by the authors.
EPIDEMIOLOGIC TRENDS IN ORAL CAVITY AND OROPHARYNGEAL CANCERS
In the United States, current estimates indicate that there are approximately 45,000 new cases and 8,500 deaths attributed to oral cavity cancers and oropharyngeal cancers annually (7) . When the incidence, survival, prognosis, and associated trends for oral cavity and oropharyngeal cancers are analyzed, it is important to recognize that previous studies have shown different epidemiologic trends for these cancers (1).
Chaturvedi et al. (2) reviewed the national data from the Surveillance, Epidemiology, and End Results (SEER) program registries from 1973 to 2004 and found that US incidence trends for oral cavity cancers remained stable up until 1982 and then declined significantly from 1983 through 2004. This was in contrast to a significant increase in incidence for oropharyngeal cancers during the same time period. Several other US epidemiologic studies, including those using more recent SEER time periods, have continued to observe the decline in oral cavity cancers along with the rise in incidence in oropharyngeal cancers (4, 6, (8) (9) (10) (11) (12) . These trends have been consistent across study populations and can be explained by their distinct etiology (13) (14) (15) (16) (17) (18) .
Public health efforts that have resulted in the decreased prevalence of tobacco use along with decreased consumption of alcohol have been cited as strong contributing factors to the decline in oral cavity cancer incidence (2, 19) . Meanwhile, it has been hypothesized that an increase in sexual practices associated with oral HPV infection among more recent birth cohorts may explain the rise in oropharyngeal cancers over time (2) .
DISPARITIES IN ORAL CANCER INCIDENCE
There are distinct epidemiologic trends based on demographic factors such as race/ethnicity, sex, and age. A study examining the national incidence trends for oral cavity cancers and oropharyngeal cancers in SEER from 1975 to 2008 found that blacks experienced a significant decline in both of these cancers beginning in 1985, with the decline being most pronounced in males. Additionally, all other racial/ ethnic-sex groups experienced a decline in oral cavity cancers over the time periods observed. The same study also found that incidence rates for oropharyngeal cancers increased 88% in white males from 1975-1979 to 2004-2008 (11) .
Studies have consistently demonstrated an increase in oropharyngeal cancers, particularly at base-of-tongue and tonsil sites, among white males since the 1990s in contrast to stable or declining rates for these cancers in other race/ ethnicity-sex groups (2, 4, 13, 14, (20) (21) (22) . A study examining SEER incidence data from 2000 to 2010 found that whites had the highest age-standardized cumulative incidence rate for oral cavity cancers during the time period, with white males experiencing the highest rates of all racial/ ethnic-sex groups. This study found a decline in oral cavity cancers in both black males and white males during the same time period but, in accordance with other studies, noted a rise in oropharyngeal cancers in white males in contrast to stable or declining trend patterns for these cancers in other racial/ethnic-sex groups (12) .
Interestingly, studies have noted an increase in cancers of the oral tongue, which are not HPV related, among white women less than 45 years of age over time (11, 20, 23) . The cause of the increase of these cancers in this specific group is not known. Studies examining these epidemiologic trends have also been consistent in their finding that oropharyngeal cancers are more frequently diagnosed in younger individuals when compared with oral cavity cancers (1, 11, 12, 22, (24) (25) (26) (27) .
DISPARITIES IN ORAL CANCER SURVIVAL
Based on race/ethnicity and anatomical location of oral cancers, differences in survival have been observed. A study analyzing SEER data from the mid-1970s to the early 1990s found that the overall, relative 5-year survival rate for oropharyngeal cancers was close to 50%, without much improvement over time. However, this study also found that, for blacks, the survival rate was closer to 30%, and this disparity in survival persisted even when stratified by stage of diagnosis. Black males, specifically, were shown to have the poorest survival of all of the race/ethnicity-sex groups analyzed during the time period in this study (28) . The results of this study were consistent with those of another investigation examining oral cancer survival statistics during a similar time period (29) .
A more recent analysis of SEER data from 1973 to 2008 found that the 5-year relative survival after diagnosis of cancers of the tongue and tonsils (oropharyngeal cancers) did not differ by sex; however, a stark difference by race/ethnicity was noted with whites displaying a survival rate of close to 60% and blacks displaying a survival rate close to 30% (20) . A study analyzing oral cancer survival data in Michigan from 1993 to 2002 also found blacks in the state to have substantially lower 5-year relative survival than their white counterparts. This study also found that, over the later time period, there was a trend of poorer survival among blacks in the state (30) . More recent estimates indicate that there has been a slight improvement in 5-year relative survival for oral cancers; however, blacks continue to experience much poorer survival than do their counterparts (31) .
Notable differences in survival based upon whether an oropharyngeal cancer is HPV positive or HPV negative have been observed (2, 32, 33) . Individuals with HPVpositive oropharyngeal cancers have been consistently shown to display significantly higher survival than those with HPV-negative oropharyngeal cancers despite the fact that these HPV-positive cancers are typically detected at later stages (2, 33) . It has been hypothesized that the improved survival among those with HPV-positive oropharyngeal cancers can be attributed to a better response of these cancers to radiation treatment and chemotherapy (2, 32, 33) .
ORAL CANCER RISK FACTORS
Tobacco and alcohol have long been identified as primary risk factors for oral cancers (34, 35) . Various other agents have been investigated, although often without clear associations. Given the wide diversity of and undersized/underpowered efforts seeking to elucidate risk factors, our review focused on meta-analyses conducted during the study time frame ) that yielded statistically significant observations. Separately, an assessment of the publications by the International Head and Neck Cancer Epidemiology (IN-HANCE) Consortium was made. INHANCE uses pooled data from consortium members, including investigations conducted in the United States.
META-ANALYSES OF ORAL CAVITY CANCER RISK FACTORS
Among these 1995-2016 meta-analyses on risk factors for oral cavity cancers, none has a primary focus on tobacco smoking (Table 1) . However, tobacco smoke is often included as an adjustment factor (36) (37) (38) (39) (40) (41) (42) (43) (44) . Among the 12 meta-analyses identified that focused on oral cavity cancer risk factors and yielded statistically significant findings (Table 1) , most frequently assessed, with 2 each, were HPV (45, 46) , alcohol (37, 38) , diet (40, 41) , and smokeless tobacco (44, 47) . Strong elevated associations (odds ratios (ORs) > 4.0) were found for heavy drinking (37, 38) , HPV (45) , and smokeless tobacco (47) . Additional noteworthy associations (ORs > 1.5) were shown for moderate drinking (38) , processed meats (40) , and socioeconomic status measured by education, occupation, and income (36) . The strongest inverse associations (ORs < 0.4) were found with fruits and vegetables (41) .
META-ANALYSES OF OROPHARYNGEAL CANCER RISK FACTORS
The search of risks associated with oropharyngeal cancers yielded only 7 meta-analyses (Table 2) (38, 40, (46) (47) (48) (49) (50) . Only alcohol has 2 meta-analyses (38, 48) . Very strong associations (ORs > 7.0) are shown for heavy drinkers and oropharyngeal cancers (38) , HPV and tonsils (46) , smoking with drinking for oropharyngeal cancers (50) , and smokeless tobacco and combined cancers of the oral cavity, pharynx, and larynx (47) . Elevated associations (ORs > 1.5) are seen for heavy drinkers and cancers of the pharynx (38) , tonsils (38) , and oral cavity/pharynx (48) ; processed meat with cancers of the oral cavity/pharynx (40); HPV with oropharyngeal cancers (46) ; tobacco smoke in a variety of intensities of exposure with oropharyngeal cancers (50); and smokeless tobacco across assessments of sites and materials (47) . Among the meta-analyses on oropharyngeal cancers, reduced odds were found only with coffee (49) .
INHANCE FOR HEAD AND NECK CANCER, ORAL CANCER, AND OROPHARYNGEAL CANCER RISK FACTORS
A multifaceted series of evaluations of oral cancer risk factors via pooled analyses from the INHANCE Consortium supplements the previous meta-analyses on oral cavity cancers and oropharyngeal cancers. This consortium has sought improved insight into risks for head and neck cancers, with more than 25 papers since 2004 when they were initiated following an inquiry into alcohol and aldehyde dehydrogenase genotypes in relation to head and neck cancer risks (51) . Web Table 1 (available at http://aje.oxfordjournals. org/) emphasizes where head and neck subsites of oral cavity, oral cavity/pharynx, oral tongue/tongue, oropharyngeal, and pharyngeal cancers are reported with statistically significant associations.
Tobacco is included as a major focus in at least 10 IN-HANCE studies including 2 studies not presented in Web Table 1 because of the complexity of reporting their results (52) (53) (54) (55) (56) (57) (58) (59) (60) (61) . It is in essentially all other studies as an adjustment factor (62) (63) (64) (65) (66) (67) (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) . They provide improved understanding of the nuances of tobacco (55) (56) (57) (58) (59) and tobacco and alcohol interactions (55, 57, 59) . Encouraging reduction in cancer risk with tobacco cessation is demonstrated (57) .
The level of detail enabled by the INHANCE studies allows for comparison of associations with oral cancer for specific exposures and subsites. The highest increased odds ratios seen were for oral cavity cancers associated with beer and wine, followed by cancer of the pharynx in association with wine and beer (69) . Many tobacco associations were found with increased odds of 3-fold or higher. These included ever tobacco use for both females and males over (56) , and numerous combinations of smoked tobacco (58) . Also particularly noteworthy are associations with 4 or more oral sex partners with oropharyngeal and tongue cancers (62) . Curiously, marijuana was shown to be either preventative or harmful on the basis of the anatomical subsite (64) . Being underweight emerged as a risk factor, while higher weights have shown a protective effect (53, 68) . Recreational physical activity (73) and healthy diet with increased intake of fruits (74) , vegetables (72, 79) , various supplements (77) , and aspects of dietary intakes (66, 71, 74, 75, 80) , as well as coffee (70) , merit further attention for potentially promising outcomes with regard to oral cancer risk.
INHANCE provided assessments for several risk factors included in Tables 1 and 2 . Most frequently studied, with 8 publications, was diet (66, 71, 72, 74, 75, 77, 79, 80) , followed by directly/indirectly smoking tobacco with 5 analyses (55-59). Alcohol (69), coffee (70) , diabetes (76) , and socioeconomic status (78) were each evaluated by 1 analysis.
Additionally, INHANCE identified significant risk factors not seen in the above oral cancer meta-analyses (Tables 1 and  2 ), such as age (52), alcohol and tobacco interaction (55, 59) and cessation (57) , family history (63), height and body mass (81) . Improved understanding of genetic interactions with etiological agents appears to be a promising means for further improvement of early detection and prevention. These studies may improve our ability to identify high-risk individuals for increased surveillance. However, it is not yet feasible to assess patient or population risk on the basis of genetic interactions with etiological agents. Genetics, therefore, is not reviewed in this paper, except for the extent there may be genetic implications regarding family history of cancer (63) .
HPV AS A DISTINCT RISK FACTOR FOR OROPHARYNGEAL CANCER
Because HPV-positive oral cavity cancers and oropharyngeal cancers are etiologically distinct, we discuss risk associated with HPV infections separately. These cancers have received much attention in the literature over the past decade.
HPVs are a heterogeneous group of DNA viruses that are classified as either high-risk (oncogenic) strains associated with cancer or low-risk strains associated with benign disease (26) . HPV is a well-established etiological factor for a subset of oropharyngeal cancers (82, 83) , specifically those found in the base of the tongue and tonsil (84) (85) (86) . To a lesser extent, oncogenic HPV subtypes have also been detected in some oral cavity cancers (87), in particular, cancers in the gingiva and oral mucosa (88) . A multicenter study conducted for the International Agency for Research on Cancer detected HPV DNA in 18.3% and 3.9% of tumor specimens from patients with oropharyngeal cancers and oral cavity cancers, respectively (89) .
HPV oncogenic subtype 16 (HPV-16) is the most prevalent HPV subtype associated with oral cancers (82, 83, (90) (91) (92) . In addition, oncogenic subtypes other than HPV-16 have also been detected in some oral cancers (82, 88, 93) .
As noted above, the incidence of HPV-related oropharyngeal cancers is highest among white males at younger ages (2, 6, 88, 90, 92, (94) (95) (96) (97) . Several studies have described a strong "age cohort effect" (2, 85, 86, 98) , which is likely because of changes in sexual practices (96) . Several collinear sexual behaviors represent primary risk factors for oral HPV infection (98, 99) , including increased oral sexual contact, younger age at sexual debut (98) , and a higher number of lifetime sexual partners (91, 92, 97) . This last association may be due to a higher number of lifetime partners engaging in oral sexual behaviors (i.e., oral sex, open-mouth kissing, oral-anal contact) rather than vaginal sex partners (94, 97, 99) . In addition to these risk factors, poor oral health has been associated with oral HPV infection, possibly through loss of epithelial barrier function resulting from ulcers, mucosal disruption, and inflammation (94) , and some studies suggest an increased risk of oral HPV infection in current smokers (91, 97) .
We have noted that HPV-positive oral cancers are recognized as distinct from HPV-negative oral cancers (10, 96) . The former are more likely to occur in nonsmokers, nondrinkers, and males (100) and also tend to have better prognoses than do HPV-negative oral cancers (96) . HPV-positive tumors are associated with longer survival time (2), reduced mortality (6, 101) , and increased sensitivity to chemotherapy and radiation therapy (96) .
Despite more favorable outcomes in HPV-related oropharyngeal cancers, their increasing incidence shows no sign of tapering off. Incident cases are expected to exceed newly diagnosed cervical cancer cases by 2020 (6) 
PREVENTION AND EARLY DETECTION
Prevention and early detection are basic components of cancer control programs (102) . These are the primary and secondary phases of disease prevention: 1) altering risk to avoid disease onset and 2) detecting early stage disease processes and stopping their progression (103) . The literature on oral cancer control pays a great deal of attention to these phases, sometimes separately, but, more typically, together.
Because several different risk factors have been identified, prevention strategies can be highly variable. Interventions can also be undertaken at various levels: communities, high-risk populations, professions and professional associations, clinical practices, and individuals at risk. Strategies have been implemented by a variety of change agents, including public health agencies, scientific investigators, community coalitions, community organizations, and clinicians and clinician organizations (104) .
Because oral cancer can appear in multiple and differentially accessible anatomical subsites of the head and neck, and because early signs and symptoms are highly variable (105), early detection can be challenging. Although precancerous lesions can be detected through visualization and palpation in the oral cavity, there are no known precancerous lesions for oropharyngeal cancer. Moreover, there remains a great deal of controversy over whether early detection through screening programs is an appropriate strategy (106) (107) (108) (109) (110) . In 2013, the US Preventive Services Task Force again found the evidence base for screening in asymptomatic adults insufficient (111) . Similarly, a recent Cochrane review concluded that the available evidence is not sufficient to warrant population-based screening programs (112) . Nevertheless, some argue that targeted screening should be conducted on the basis of weaker evidence of potential benefit (109, 110).
As described above, primary prevention for oral cavity cancers appears to have received a large boost from decades of public health efforts to discourage tobacco use (113) . Epidemiologic studies point to the coincidence of tobacco use reductions achieved over decades of multifaceted interventions across the country and a lagged and sustained reduction in oral cancer incidence rates (11, 114) . The tobacco campaigns were generally not directed toward reducing oral cavity cancers but were apparently quite successful in doing so nevertheless. Some studies have focused on assessing and improving the role of health-care providers in promoting tobacco cessation specifically to reduce oral cancer incidence further (115) (116) (117) (118) (119) (120) (121) (122) (123) (124) . Similar contributions to oral cancer incidence reduction may also have occurred in association with broad campaigns to reduce alcohol abuse and improve physical activity and nutrition, campaigns not directed specifically at oral cancers, but possibly affecting them nevertheless. To examine these broad campaigns is beyond the scope of the current review.
Several studies have investigated public awareness of oral cancer and means of improving prevention and early detection practice, either generally (125) (126) (127) (128) or in specific, at-risk populations including smokers (129, 130) , blacks (131-133), Latinos (134, 135) , and rural populations (136) (137) (138) . Studies consistently find that public knowledge of oral cancer and receipt of early detection examinations have been and continue to be limited. Although some studies have suggested racial and ethnic differences, with Hispanics and blacks being less aware and having more limited early detection services (115, 128) , studies have also concluded that the differences are ultimately attributable to health literacy, education, and income disparities rather than race or ethnicity (127, 137, 139) . Tobacco-use status, an indicator of elevated risk, does not appear to increase the likelihood of having an examination (124, 129, 130, 140) . Fear of cancer may be negatively associated with having an examination in some high-risk populations (132, 133) , although being concerned about cancer has also been shown to be positively associated with getting an examination (140) .
Some studies have investigated the educational materials to which the public has access. Most have found sources of information inadequate, even misleading (141) (142) (143) (144) (145) . Some have specifically linked awareness to preventive behaviors (127, 129, 135) , although causal paths remain uncertain. Health behavior theories typically do not link knowledge directly to behavior (146) , but knowledge is a necessary first step, and a need for improved health information dissemination is recognized (147, 148) .
A variety of strategies have been reported for improving public awareness of and access to early detection services (104) . Mass media campaigns have shown some success in increasing awareness and demand for screening services (149, 150) . Success in increasing public awareness generally, however, has been limited (151, 152) . Billboards have not shown promise as a message delivery mechanism for improving oral cancer awareness in populations at risk (153) .
Clinician awareness of oral cancer and behavior directed at risk reduction in patients have also been investigated (154, 155) . Many of these studies are limited to specific states or even regions of states. Investigators have examined dentists (121, 122, 147, 148, (156) (157) (158) (159) (160) (161) (162) , dental hygienists (116, 118, (162) (163) (164) (165) (166) (167) , physicians (158, 159, 168) , and other primary care providers (168) (169) (170) . Generally, studies have found provider knowledge and behavior not to be optimal. Much need for improvement has been identified across these many investigations, and a need for training programs has been emphasized (154, 160) . However, studies of provider training programs' oral cancer content do not suggest that much improvement is coming (167, 171, 172) .
The literature finds that clinicians lack early detection skills and do not sufficiently engage in risk counseling. Clinicians are generally more likely to discuss tobacco with their patients than alcohol. They are even less likely to discuss sexual practices (166, 173, 174) .
Studies have reported efforts to improve clinician practice through continuing education (120, 175) and other interventions. Internet-based support for tobacco cessation counseling in dental offices showed modest success in a randomized trial (123) . Online training improved intent to counsel and perceived self-efficacy for alcohol counseling also. There is some evidence that more recently trained clinicians may be more aware and vigilant in primary and secondary prevention practice (120, 157) .
Having a dental visit improves the likelihood of having an oral cancer examination (129, 130) . Dentists are much more likely than physicians to perform oral cancer examinations (159) . Nevertheless, clinical diagnosis is very difficult, and histological confirmation is required (175, 176) . Clinical diagnostic adjuncts being promoted in dentistry have limited value (107, 177) .
With the rising incidence of oropharyngeal cancers, the literature has reflected limited interest in promoting awareness of HPV, its link to oropharyngeal cancers, the need for safe sexual practices and, where appropriate, vaccination. In fact, there is an extensive literature regarding promotion of HPV vaccination. However, the focus of that literature is primarily on cervical cancer rather than oropharyngeal cancer, putting it outside the scope of this review. The work by Daley et al. (161, 173) represents a notable exception. Their investigations determined that dentists and dental hygienists are not adequately prepared to counsel patients about HPV and that interventions are needed.
DISPARITIES AND COST OF CARE
Disparities in oral cancers across different population groups, particularly between whites and blacks, are persistent challenges that have defied efforts at intervention. The literature suggests that the underlying reasons are complex, involving risk behavior patterns, genetic differences, differential access to care, and variable quality of care. The extent to which race is a primary factor in health disparities is an important empirical question that remains to be resolved (178) .
Oral cancers are among the most expensive cancers to treat. A 2012 paper estimates that oropharyngeal cancers alone have an annual direct medical cost of $300 million in the United States (179) . One study estimated that the lifetime cost for each oropharyngeal and oral cavity cancer case ranges from $15,340 to $46,800, with an average cost of $33,020 (180). Lee et al. (181) , using 2008 Nationwide Inpatient Sample data involving 17,632 hospitalizations, estimated a total hospitalization cost for oral cavity cancers (including lip and salivary gland) and oropharyngeal cancers at $1.08 billion, or $62,885 per hospitalization. These costs account only for direct, inpatient costs of care. The cost of oral cavity and oropharyngeal cancers in both years of life and lost productivity is also high. One study estimated the years of potential life lost at 63,587 (182) . Late-stage cancers have been estimated to cost 36% more than localized disease in the first year after diagnosis (183) .
Cost drivers identified in the Medicare population include demographics, comorbidities, and treatment selection (184) . Complications and adjuvant therapies increase the cost of care dramatically (181, 185) . Treatments confined to surgery are least expensive (186) .
Oropharyngeal cancers are generally more expensive to treat than oral cavity cancers (184) . Privately insured patients' cancers cost far more than Medicaid-and Medicarecovered patients' cancers, in that order (187) . There is evidence that out-of-pocket costs may lead some oral cancer patients to abandon their medications (188) .
Racial and ethnic disparities in incidence and survival are numerous, as described elsewhere in this review. Black Americans, particularly black men (189), have poorer outcomes than whites (190) . They have historically had poorer survival rates (90, (191) (192) (193) (194) . One study, however, did not find self-reported race or degree of West African ancestry to be associated with survival, suggesting that other factors such as stage at diagnosis may be underlying causes of apparent racial differences (195) . Colevas (13) , for example, found the highest incidence rates for oropharyngeal cancers to be in low socioeconomic status groups. Riley et al. (137) found that apparent racial and ethnic disparities in receiving early detection services were actually attributable to differences in health literacy and socioeconomic status. High rates of tobacco and alcohol use are also associated with poorer survival (196) . Tobacco use and other health-limiting behaviors are associated with racial/ethnic minority status and socioeconomic disparities (197, 198) .
Disadvantages are not confined to blacks versus whites. The US-born population, for example, has been shown to have better survival rates than citizens born outside the United States (199) . Suárez et al. (200) found that Puerto Rican men have higher incidence and mortality rates than men on the US mainland including Hispanic men, non-Hispanic black men, and non-Hispanic white men. This may be a consequence of quality of care or access to care, the authors conclude. Morse et al. (201) found that a lower percentage of in situ cancers is detected in Puerto Rico versus the mainland United States and suggested that limited access to care is the underlying cause of late diagnosis.
Lack of access to quality care may be contributing to greater adverse outcomes in blacks as well (192) . Treatment at academic centers, lack of need for adjuvant therapy, and private insurance all have been associated with improved outcomes (202) . In the case of oral cancers, access to oral health care is particularly important. Late-stage disease and larger tumors have been linked to less than annual dental visits (203, 204) . Regular dental visits are associated with having an oral cancer examination (129, 130, 138) . Dentists, of all primary care providers, are the most likely to perform these examinations (159) . However, if blacks do receive an examination, it is more likely to be from someone other than a dentist (205) .
Lower incidence rates of HPV-positive cancers have been attributed to poorer survival in blacks (90, 193) . HPV positivity is generally associated with improved survival (206) .
A recent study with a small sample has found, though, that HPV-positive tumors in blacks disproportionately lacked the tumor suppressor gene P16, which may suggest yet another mechanism underlying the observed racial disparity in survival (207) .
The quality of health care received by blacks has been found to be lacking compared with that of whites. Blacks have been shown, for example, to be less frequently recommended for surgery even when controlling for factors like tumor stage and patient age (90, 191, 208) . Nevertheless, their treatment may actually cost more overall than that of whites, likely a consequence of comorbidities confounding treatment (184) . Blacks have also been shown to lack health insurance and to have poorer overall health compared with whites (209) , which may also account for poorer cancerspecific survival.
DISCUSSION
Reducing the incidence of oral cancers, improving clinical outcomes, and eliminating disparities pose significant public health challenges. Oral cancers are common in medically and dentally underserved populations and are difficult to detect and diagnose at early stages of disease. Furthermore, population risk profiles are complex and shifting, which makes it hard to target high-risk populations with focused and sustained campaigns.
Although we have documented a decline in incidence of oral cavity cancers over time, that appears to be an indirect outcome of intensive, multifaceted and sustained tobacco control efforts not directed toward oral cancer prevention. Despite some 20 years of cancer control activity directed at improving public awareness of oral cancers, increasing demand for early detection services, and preparing the health workforce for engaging in prevention and early detection practices, there is no evidence that any of that has made any substantial difference. Intervention opportunities and promising mechanisms for intervention have been demonstrated, but much work is still needed to build on that base and extend the programming to all high-risk populations, those currently identified and those yet to be discovered.
Improvements are needed in all phases of cancer control from prevention to early detection to disease management. The information generated by this review can inform practice and policy for environmental and systems changes that can reduce the burden of oral cancers.
Among the challenges identified is a normative environment in which oral health is not a priority. There is a demonstrated need for intensive health promotion campaigns aimed at changing attitudes toward oral health and increasing demand for oral health services that can contribute to both risk reduction and earlier diagnosis.
With an educated and motivated public demanding oral health services, a need for expanded access to care would be required. Every patient should have a medical home and a dental home, preferably in a single setting, where the range of preventive and diagnostic services can be offered with all required expertise.
Primary care providers from diverse professional backgrounds can play roles in oral cancer control by educating patients about risk and delivering competent diagnostic services (210). However, before that can be accomplished on a meaningful scale, clinicians need to be empowered with the required clinical skills, and oral cancer control must become a clinical priority. This review has identified a number of deficiencies, as well as promising strategies for improving workforce performance. These investigations should be continued as a matter of public policy.
In addition, the workforce needs to be expanded in order to provide more and better services to underserved populations that are most at risk for oral cancer and poor outcomes. One strategy for improving access to oral health care has been to authorize midlevel providers, such as dental therapists. Dental therapists have been providing services to tribal populations in Alaska for nearly a decade. Therapists have also been expanding access to oral health care in Minnesota since 2011. Just this year both Maine and Vermont have enacted statutes authorizing alternative providers. These model programs are being evaluated positively, although not specifically, for their contributions to prevention and detection of oral cancer (211) (212) (213) . Nevertheless, this is one promising alternative for improving access to oral health services with the potential for extending oral cancer prevention and early detection services that other states should consider testing and evaluating.
There are a number of policy options for inducing clinicians to provide care to underserved populations (214) . Among these policies are financial incentives, such as loan forgiveness programs, which governments at all levels can explore and adopt to their specific area needs in order to expand access to care in underserved populations. Further investigation is needed, however, to identify successful strategies (215, 216) .
Risk reduction can also be accomplished through policies aimed at limiting tobacco use and promoting HPV vaccination. Tobacco remains the single most important oral cancer risk factor, and even limited smoking and passive smoking can contribute to the disease burden. Tobacco control programs have been effective in reducing smoking rates in the United States, but more remains to be done, particularly in preventing youth uptake. Tobacco 21 policies, which require purchasers of tobacco products to be at least 21 years of age, should be enacted by states and local governments to limit access to tobacco products by youth. In addition, the Food and Drug Administration now has expanded authority to regulate tobacco products, and that authority can and should be directed toward youth uptake prevention. Healthy People 2020 offers a number of strategies for tobacco control, and state and local governments should assess their alternatives and adopt programs to meet their local needs (217) .
HPV vaccination could possibly prevent a majority of oropharyngeal cancers. Vaccines are available and authorized, but uptake and course completion remain challenges (218) . States should consider mandatory vaccination programs that have been adopted in a small number of jurisdictions (219) . The programs of these early adopters should be evaluated and the results disseminated to inform policy makers elsewhere. There are a number of health promotion resources available for public education and for adaptation to clinical practice that may be used to encourage both uptake and course completion (220) .
Finally, we need to promote interprofessional health-care models that coordinate care across disciplines. Progress in risk reduction and early detection could be greatly enhanced if oral health were regarded as systemic health, and care between dentists and physicians was integrated (221) . Collaborative care with all the needed expertise (internal medicine, oral medicine, otolaryngology, oral surgery, general dentistry, oncology) should be a national priority. One approach would be to amend the Affordable Care Act to require oral health care to be fully integrated into accountable care organizations.
Dissemination of medical and dental research findings across disciplines also requires specific efforts to ensure evidence based practice. Keeping the health-care workforce abreast of the evolving evidence base should be a priority. Interprofessional continuing education programs should be promoted. Such programs should enable providers to have current understanding of population risk profiles. Clinicians must be attentive to changing population characteristics in the increasingly diversified US populace.
These efforts can be informed by high-quality, powerful research designs, such as the collaborative work of the IN-HANCE Consortium. Much is gained, for example, from the attention given by INHANCE to tobacco exposures and cessation. Findings from INHANCE include the relationships of oral cancer with involuntary smoking (56), low levels of smoking (59) , and different smoked tobacco products (58) . These observations suggest inclusion of oral cancer in prevention efforts for other cancers, such as lung cancer. Assessment of combinations of tobacco products suggests that cigarettes conceal the independent risks of cigars and pipes (58) . The Consortium also provides insight into the relative contributions to oral cancer risk by tobacco and alcohol alone and together, clarifying the independence of high alcohol exposure and oral cancer risk (55, 69) and differential responses to cessation of tobacco smoking (risk reduction in 1-4 years) or alcohol (risk reduction at 20 or more years) (57) . The detailed work provided by INHANCE on tobacco exposure is an example of evidence that has the potential for policy development and evidence-based practice.
Risk patterns and epidemiologic trends are subject to much variability over time. Yet, public-health and scholarly focus cannot be allowed to shift solely to the rising trends in HPV-related oral cancers. Efforts to promote tobacco control, alcohol use reduction, improved dietary practices, and physical activity still need to be continued with vigor. As demographic variation is associated with variable risk profiles, it is important to monitor and adapt to these changing demographics and associated risks as health policy moves into the future (167). Surveillance mechanisms need to be in place, and clinicians need current surveillance data on which to base clinical decisions. Future assessments of oral cancer risk factors in the United States are likely to include factors currently seen at the global level but have not been examined in US studies. The United States is a diverse country with high levels of immigration. As the immigrant population swells, new risk factors can be expected to emerge and require public health attention (222) . Anticipated factors include such exposures as betel (223) (224) (225) , bidi (226) , and mate (227) .
Finally, improved capacity to detect early stage disease is needed. Targeting high-risk populations remains a blunt instrument because of a lack of refinement in our knowledge of risk factor interactions. Genetic predispositions to disease progression in both oral cavity and oropharyngeal cancers need to be more fully understood in order to target risk reduction and early detection interventions more precisely.
This review has significant limitations that should be acknowledged. We confined the study to a limited time frame. This temporal limitation caused us to exclude literature that might have enabled a more comprehensive discussion of oral cancers. We also elected to confine the study to the US population, thus disallowing an exploration of the rich literature produced from other countries, particularly with respect to risk factors. The choice to restrict the study was necessary, however, to allow us to focus on the contrasts between oral cavity and oropharyngeal cancers and the current understanding of underlying risks that appear to be responsible for the observed trends. As oral cancers are extremely heterogeneous with many risk factors that vary in relevance across different regions of the world, it was not considered possible to take a broader view.
CONCLUSION
Oral cancers present a significant and difficult public health challenge. Although frequently regarded as a homogeneous group of cancers, it is clear that their complexity is subtle and in part driven by anatomical site differences. Although it is clear that HPV-positive oral cancers are etiologically distinct from HPV-negative oral cancers, these distinct etiologies are not fully understood. Additional research is needed to fully understand oral cancers and also to inform effective interventions targeting at-risk populations and the health-care workforce that serves them.
Promising strategies include health education and improved access to better informed and organized care. Clinical practice needs to be improved, and the health-care workforce needs to be trained, encouraged, and enabled to address the continuing and ever changing challenges these cancers present. Extensive, multilevel campaigns modeled on the successes of tobacco control are recommended.
